Showing 201 - 220 results of 442 for search '"glaucoma"', query time: 0.05s Refine Results
  1. 201
  2. 202

    Effect of a Topical Combination of Latanoprost and Pranoprofen on Intraocular Pressure and the Ocular Surface in Open-Angle Glaucoma Patients by Simin Zhu, Dabo Wang, Jing Han

    Published 2018-01-01
    “…A prospective study was performed to observe the effects of nonsteroidal anti-inflammatory drug (NSAID) eyedrops on intraocular pressure (IOP) and the ocular surface in primary open-angle glaucoma (POAG) patients treated with 0.005% latanoprost eyedrops. …”
    Get full text
    Article
  3. 203

    Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma by Anton Hommer, Douglas A. Hubatsch, Juan Cano-Parra

    Published 2015-01-01
    “…This was a 12-week, open-label, single-arm study of patients with open-angle glaucoma or ocular hypertension with intraocular pressure (IOP) not sufficiently controlled after ≥4 weeks of PGA monotherapy. …”
    Get full text
    Article
  4. 204

    Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model by Xing Tu, Zixing Zou, Jiahui Li, Simiao Zeng, Zhengchao Luo, Gen Li, Yuanxu Gao, Kang Zhang, Jing Ni

    Published 2025-01-01
    “…Retinal ganglion cell (RGC) death caused by acute ocular hypertension is an important characteristic of acute glaucoma. Receptor-interacting protein kinase 3 (RIPK3) that mediates necroptosis is a potential therapeutic target for RGC death. …”
    Get full text
    Article
  5. 205

    Surgical Outcomes of Trabeculectomy in Uveitic Glaucoma: A Long-Term, Single-Center, Retrospective Case-Control Study by Rina Kanaya, Riki Kijima, Yasuhiro Shinmei, Akihiro Shinkai, Takeshi Ohguchi, Kenichi Namba, Shinki Chin, Susumu Ishida

    Published 2021-01-01
    “…To evaluate the long-term outcomes of trabeculectomy with mitomycin C (MMC-TLE) in patients with uveitic glaucoma (UG). Patients and Methods. This was a retrospective, nonrandomized case series study. …”
    Get full text
    Article
  6. 206
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211
  12. 212

    Effect on Intraocular Pressure of Switching from Latanoprost and Travoprost Monotherapy to Timolol Fixed Combinations in Patients with Normal-Tension Glaucoma by Ryoko Igarashi, Tetsuya Togano, Yuta Sakaue, Takaiko Yoshino, Jun Ueda, Takeo Fukuchi

    Published 2014-01-01
    “…To evaluate the effect on intraocular pressure (IOP) of switching from latanoprost and travoprost monotherapy to timolol fixed combinations in Japanese patients with normal-tension glaucoma (NTG). Methods. 27 NTG patients (54 eyes) were compared IOP, superficial punctuate keratitis (SPK) scores, and conjunctival injection scores in eyes treated with prostaglandin (PG) or PG analog/beta-blocker (PG/b) fixed-combination 6 months after the change in therapy. …”
    Get full text
    Article
  13. 213

    Ab Externo Choroidal Fluid Drainage, Pars Plana Vitrectomy, and Endotamponade for the Management of Persistent Hypotony following Glaucoma Surgery by Susanna Friederike Koenig, Efstathios Vounotrypidis, Christian Maximilian Wertheimer, Armin Wolf

    Published 2024-01-01
    “…Persistent severe serous choroidal detachment is a rare complication after glaucoma surgery. Surgical treatment with choroidal fluid drainage through a scleral incision is an option in these cases. …”
    Get full text
    Article
  14. 214
  15. 215

    Diagnostic Decision-Making Variability Between Novice and Expert Optometrists for Glaucoma: Comparative Analysis to Inform AI System Design by Faisal Ghaffar, Nadine M. Furtado, Imad Ali, Catherine Burns

    Published 2025-01-01
    “…These guidelines will assist in developing AI systems for glaucoma diagnosis, ultimately enhancing the diagnostic accuracy of optometrists and minimizing inconsistencies in their decisions. …”
    Get full text
    Article
  16. 216

    Real-World Efficacy and Safety of Tafluprost in Primary Open-Angle Glaucoma Patients with Corneal Disorders: A Taiwan Experience by Ju-Kuo Lin, Fu-Tsung Wei, Yi-Chun Liu, Yung-Chang Yen

    Published 2022-01-01
    “…To investigate the efficacy and safety of switching to 0.0015% tafluprost ophthalmic solution with reduced benzalkonium chloride (BAK) on primary open-angle glaucoma (POAG) patients with corneal disorders under 0.005% latanoprost treatment. …”
    Get full text
    Article
  17. 217
  18. 218
  19. 219

    First-line glaucoma monotherapy medication patterns in Finland during 1995-2019 based on a population-based study. by Petri K M Purola, Seppo V P Koskinen, Hannu M T Uusitalo

    Published 2025-01-01
    “…<h4>Background</h4>The long-term patterns in first-line glaucoma medication are not well established. Exploring these in longitudinal and population-based settings would provide information for the healthcare systems to plan glaucoma care accordingly.…”
    Get full text
    Article
  20. 220